Latest News for: alpha tau

Edit

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference (Form 6-K) (Alpha Tau Medical Ltd)

Public Technologies 18 Dec 2025
Alpha Tau> to Present at the J.P ... JERUSALEM, December 18th, 2025 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ ... About Alpha Tau Medical Ltd ... Alpha Tau Medical Ltd.
Edit

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

Nasdaq Globe Newswire 18 Dec 2025
- The overview presentation will review some of the ...
Edit

Alpha Tau Medical up sharply as brain cancer trial begins

Virtual Jerusalem 14 Dec 2025
The company’s share price rose 21% on Nasdaq last week.|�Read More�Front – Globes ....
Edit

Notice of Proposed Sale of Securities (Form 144) (Alpha Tau Medical Ltd)

Public Technologies 11 Dec 2025
) ... You can access the original document here ... Disclaimer. Alpha Tau> Medical Ltd.
Edit

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent

Hastings Tribune 09 Dec 2025
- First patient in the world treated with Alpha DaRT®in the brain – ... .
Edit

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma ...

Nasdaq Globe Newswire 09 Dec 2025
- First patient in the world treated with Alpha DaRT® in the brain – ... .
Edit

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University (Form 6-K) (Alpha Tau Medical Ltd)

Public Technologies 09 Dec 2025
Alpha Tau> Successfully Treats First Patient in its U.S ... Uzi Sofer, CEO of Alpha Tau, stated, "This is a historic day for Alpha Tau and for GBM patients around the world, with the first treatment ever of a brain cancer using Alpha DaRT.
Edit

Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium (Form 6-K) (Alpha Tau Medical Ltd)

Public Technologies 04 Dec 2025
Alpha Tau> Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium ... JERUSALEM, December 4, 2025 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ ... Alpha Tau Medical Ltd.
Edit

Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO ...

Nasdaq Globe Newswire 04 Dec 2025
Pancreatic cancer multi-center clinical trial in U.S.
Edit

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

Nasdaq Globe Newswire 02 Dec 2025
- FDA approval marks Alpha Tau>’s fifth simultaneous ...
Edit

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer (Form 6-K) (Alpha Tau Medical Ltd)

Public Technologies 02 Dec 2025
Alpha Tau> Receives FDA Approval to ... - FDA approval marks Alpha Tau's fifth simultaneous active U.S ... JERUSALEM, December 2, 2025 - Alpha Tau Medical Ltd ... Den, Alpha Tau Chief Medical Officer ... About Alpha Tau Medical Ltd ... Alpha Tau Medical Ltd.
Edit

Alpha Tau to Participate in December Investor Conferences

Nasdaq Globe Newswire 01 Dec 2025
01, 2025 (GLOBE NEWSWIRE) -- Alpha Tau> Medical Ltd. ("Alpha ...
Edit

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

The Eagle-Tribune 20 Nov 2025
- Alpha DaRT pancreatic cancer patient treatments underway inU.S.multi-center pilot study- ... .
Edit

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update (Form 6-K) (Alpha Tau Medical Ltd)

Public Technologies 20 Nov 2025
... momentum at Alpha Tau>, as the pace of patient treatments continues to rise, and we draw increased interest from our peers in the industry" said Alpha Tau Chief Executive Officer Uzi Sofer.
Edit

Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

Nasdaq Globe Newswire 11 Nov 2025
11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau> Medical Ltd. ("Alpha Tau", ...

Article Search

tools
×
×
×
×